Search

Your search keyword '"J. Vissing"' showing total 544 results

Search Constraints

Start Over You searched for: Author "J. Vissing" Remove constraint Author: "J. Vissing"
544 results on '"J. Vissing"'

Search Results

1. Low aerobic capacity in McArdle disease: A role for mitochondrial network impairment?

2. European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience

4. 1st FSHD European Trial Network workshop:Working towards trial readiness across Europe

8. 249th ENMC International Workshop: The role of brain dystrophin in muscular dystrophy: Implications for clinical care and translational research, Hoofddorp, The Netherlands, November 29th–December 1st 2019

9. Intrarater reliability and validity of outcome measures in myotonic dystrophy type 1

10. Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation

11. Botulinum toxin treatment improves dysphagia in patients with oculopharyngeal muscular dystrophy and sporadic inclusion body myositis

21. LGMD

22. METABOLIC MYOPATHIES

23. 211th ENMC International Workshop

24. SMA - TREATMENT

25. IMAGING

26. LGMD

27. METABOLIC MYOPATHIES

28. OTHER NMDs

29. MITOCHONDRIAL DISEASES

30. MUSCLE IMAGING – MRI

31. Exercise training in metabolic myopathies

32. AUTOPHAGIC MYOPATHIES / MYOFIBRILLAR MYOPATHIES / DISTAL MYOPATHIES / POMPE DISEASE

33. MUSCLE FUNCTION & HOMEOSTASIS / MOLECULAR THERAPEUTIC APPROACHES

34. MYASTHENIA & RELATED DISORDERS

35. P.58No effect of resveratrol supplementation in patients with mitochondrial myopathy - a randomized, double-blind, placebo-controlled, cross-over study

36. P.69NEO1 and NEO-EXT studies: exploratory efficacy of repeat avalglucosidase alfa dosing for up to 5 years in participants with late-onset Pompe disease (LOPD)

37. EP.54Assessment of trunk muscle strength in patients with muscular dystrophies using stationary and hand-held dynamometry: a test-retest reliability study

38. P.375Does rhythmic auditory stimulation influence walking speed in the 6-minute walk test in patients with myasthenia gravis?

39. LIMB-GIRDLE MUSCULAR DYSTROPHY I

40. METABOLIC MYOPATHIES I

41. O.5A new glycogen storage disorder caused by a dominant mutation in the glycogen myophosphorylase gene (PYGM)

42. P.30Reliability of balance, function, and muscle strength measures in myotonic dystrophy type 1

43. P.306Multicentric MRI study in a cohort of FSHD2 patients: pattern definition and differences between FSHD1 and FSHD2

44. P.277Muscle contractility in spinobulbar muscular atrophy

46. P.299Disease progression using quantitative MRI outcome measures in limb girdle muscular dystrophy 2L

47. EP.07Impaired lipolysis in propionic acidemia - a case story

48. P.119Analysis of the structural and metabolic consequences of McArdle disease using the murine model

50. P.180Paraspinal muscle affection in limb-girdle muscular dystrophy type 2I patients

Catalog

Books, media, physical & digital resources